Dose-related Allergic Reactions Decrease Over Time During Peanut Oral Immunotherapy in a Large, Randomized, Double-blind, Placebo-controlled, Phase 2 Study - 24/02/20
Doi : 10.1016/j.jaci.2019.12.530
Andrew Long 1, Natasha Purington 1, Sandra Andorf, PhD 1, Katherine O'Laughlin 1, Shu-Chen Lyu 1, Sayantani Sindher, MD 1, Monali Manohar Manohar, PhD 1, Scott Boyd 2, Robert Tibshirani, PhD 2, Holden Maecker 2, Kaori Mukai 2, Mindy Tsai 2, Manisha Desai, PhD 2, Sharon Chinthrajah, MD 1, Stephen Galli, MD 2, Kari Nadeau, MD PhD FAAAAI 1
1 Stanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research
2 Stanford University
426
El texto completo de este artículo está disponible en PDF.Esquema
© 2020
Publicado por Elsevier Masson SAS.
Vol 145 - N° 2S
P. AB134 - février 2020 Regresar al número
Artículo precedente
- Safety of Oral Immunotherapy Associated With Omalizumab In Severe Cow's Milk Allergy
- Ana Flavia Sousa, Ariana Yang, Cintia G. Mendes, Karine Boufleur, Pablo Torres, Patricia Salles-Cunha
- Differences In Transcriptional Phenotype Between Highly Reactive And Hyporeactive Peanut Allergic Patients Are Not Reflected In Different Outcomes Of Oral Immunotherapy
- David Pyle, Yamini Virkud, Bert Ruiter, Neal Smith, Wayne Shreffler
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?